Lim, Bernard — Insider Profile

Insider Profile

Lim, Bernard

$CRDL

Companies Filed At

Open-Market Buys (2yr)

$20K

Buy Value (2yr, open-market)

Dec 03, 2025

Most Recent Trade

Credibility
Score

Hit Rate

-22.7%

Avg 90d Return

-13.3%

Median 90d Return

Evaluated Trades

-2.2%

Best Trade

-51.8%

Worst Trade

Hit rate and returns are based on 7 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Dec 03, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	250,000	$1.40	$350K	45
Dec 17, 2024	$CRDL Cardiol Therapeutics Inc	—	Open Market	Buy	10,000	$1.95	$20K	45
Jul 10, 2024	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	285,000	—	—	45
Dec 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	14,323	—	—	45
Dec 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	14,323	—	—	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	424,667	$1.41	$599K	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	424,667	$1.41	$599K	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Expiry	Sell	400,000	—	—	45
Feb 24, 2021	$CRDL Cardiol Therapeutics Inc	—	Exercise	Sell	10,000	$3.25	$32K	45
Feb 24, 2021	$CRDL Cardiol Therapeutics Inc	—	Exercise	Buy	10,000	$3.25	$32K	45

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Signal scores reflect the company's current score, not the score at time of trade.